Salidroside protects against myocardial infarction via activating MIF-mediated mitochondrial quality control
Abstract Background Salidroside is a potential therapeutic agent for myocardial infarction (MI), exerting therapeutic effects on macrophage migration inhibitory factor (MIF)-regulated mitochondrial quality control. Our aim was to explore the mechanism through which the MIF pathway regulates salidros...
| Published in: | Chinese Medicine |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13020-025-01076-3 |
